Increasing hepatitis c prevalence and associated risk behaviors among incarcerated young adults

Journal of Urban Health

Volumn 91, Issue 2, 2014, Pages 376-382

  McNamara, Blair C ^a   Losikoff, Phyllis T ^b,c   Huguenin, Linda ^b   Macalino, Grace E ^d   Rich, Josiah D ^b,c,e   Gregory, Stephen H ^b,c  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^e Center for Prisoner Health and Human Rights   (United States)

Author keywords

Hepatitis C; Incarceration; Injection drug use; Rhode Island; Young adult

Indexed keywords

ADOLESCENT; ADULT; COMORBIDITY; DRUG ABUSE; EDUCATION; FEMALE; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; INCIDENCE; MALE; PREVALENCE; PRISONER; PSYCHOLOGY; RISK REDUCTION; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; COMORBIDITY; FEMALE; HEPATITIS C; HUMANS; INCIDENCE; MALE; NEEDLE SHARING; PREVALENCE; PRISONERS; RHODE ISLAND; RISK REDUCTION BEHAVIOR; RISK-TAKING; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84898903064     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1007/s11524-013-9807-x     Document Type: Article

References (18)

1. Weinbaum C, Lyerla R, Margolis HS. Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2003; 52(RR-1): 1-36.
2. Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health. 2000; 90(10): 1562-9.
3. Committee on the Prevention and Control of Viral Hepatitis Infections, Institute of Medicine. Hepatitis and liver cancer; a national strategy for prevention and control of hepatitis B and C. National Academies Press, 2010.
4. Macalino GE, Vlahov D, Dickinson BP, Schwartzapfel B, Rich JD. Community incidence of hepatitis B and C among reincarcerated women. Clin Infect Dis. 2005; 41(7): 998-1002.
5. Drucker E. Drug prohibition and public health: 25 years of evidence. Public Health Rep. 1999; 114(1): 14-29.
6. Hunt DR, Saab S. Viral hepatitis in incarcerated adults: a medical and public health concern. Am J Gastroenterol. 2009; 104(4): 1024-31.
7. De Groot AS, Stubblefield E, Bick J. Hepatitis C: a correctional-public health opportunity. Medscape Infect Dis. 2001; 3: 1-11.
8. Boutwell AE, Allen SA, Rich JD. Opportunities to address the hepatitis C epidemic in the correctional setting. Clin Infect Dis. 2005; 40(Suppl 5): S367-72.
9. Amon JJ, Garfein RS, Ahdieh-Grant L, Armstrong GL, Ouellet LJ, Latka MH, Vlahov D, Strathdee SA, Hudson SM, Kerndt P, Des JD, Williams IT. Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. Clin Infect Dis. 2008; 46(12): 1852-8.
10. Onofrey S, Church D, Kludt P, DeMaria A, Cranston K, Beckett GA, Holmberg SD, Ward JW, Holtzman D. Centers for disease control and prevention. Hepatitis C virus infection among adolescents and young adults-Massachusetts, 2002-2009. MMWR Morb Mortal Wkly Rep. 2011; 60: 537-41.
11. Miller CL, Johnston C, Spittal PM, Li K, Laliberte N, Montaner JS, Schechter MT. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology. 2002; 36(3): 737-42.
12. Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, Rich JD. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004; 94(7): 1218-23.
13. Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18(Suppl 1): S11-9.
14. De P, Cox J, Boivin JF, Platt RW, Jolly AM. The importance of social networks in their association to drug equipment sharing among injection drug users: a review. Addiction. 2007; 102(11): 1730-9.
15. Baillargeon J, Wu H, Kelley MJ, Grady J, Linthicum L, Dunn K. Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system. Public Health. 2003; 117(1): 43-8.
16. Kim JY, Rich JD, Zierler S, Lourie K, Vigilante K, Normandie L, Snead M, Renzi J, Bury-Maynard D, Loberti P, Richman R, Flanigan TP. Successful community follow-up and reduced recidivism in HIV positive women prisoners. J Correctional Health Care. 1997; 4: 5-16.
17. Flanigan TP, Zaller N, Beckwith CG, Bazerman LB, Rana A, Gardner A, Wohl DA, Altice FL. Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention. J Acquir Immune Defic Syndr. 2010; 55(Suppl 2): S78-83.
18. Spaulding AC, Thomas DL. Screening for HCV infection in jails. JAMA. 2012; 307(12): 1259-60.